People: Bayer AG (BAYZF.PK)

Summary

Name	Age	Since	Current Position
Werner Wenning	66	2012	Chairman of the Supervisory Board
Marijn Dekkers	55	2010	Chairman of the Management Board, Chief Executive Officer
Hermann Strenger			Honorary Chairman of the Supervisory Board
Thomas de Win	54	2006	Vice Chairman of the Supervisory Board
Werner Baumann	50	2010	Member of the Management Board, Responsible for Finance
Wolfgang Plischke	61	2006	Member of the Management Board, Responsible for Innovation, Technology and Environment
Michael Koenig	49	2013	Member of the Management Board responsible for Human Resources
Paul Achleitner	56	2002	Member of the Supervisory Board
Clemens Boersig	64	2007	Member of the Supervisory Board
Thomas Ebeling	54	2012	Member of the Supervisory Board
Thomas Fischer	57	2005	Member of the Supervisory Board
Peter Hausmann	59	2006	Member of the Supervisory Board
Reiner Hoffmann	57	2006	Member of the Supervisory Board
Yueksel Karaaslan	45	2012	Member of the Supervisory Board
Klaus Kleinfeld	55	2005	Member of the Supervisory Board
Petra Kronen	48	2000	Member of the Supervisory Board
Helmut Panke	66	2007	Member of the Supervisory Board
Sue Rataj	56	2012	Member of the Supervisory Board
Petra Reinbold-Knape	54	2012	Member of the Supervisory Board
Michael Schmidt-Kiessling	54	2012	Member of the Supervisory Board
Ekkehard Schulz	71	2005	Member of the Supervisory Board
Klaus Sturany	66	2007	Member of the Supervisory Board
Andre van Broich	42	2012	Member of the Supervisory Board
Ernst-Ludwig Winnacker	71	1997	Member of the Supervisory Board
Oliver Zuehlke	44	2007	Member of the Supervisory Board
Alexander Rosar			Head of Investor Relations

» Insider Trading

Biographies

Name	Description
Werner Wenning	Mr. Werner Wenning has been Chairman of the Supervisory Board of Bayer AG as of October 1, 2012. Prior to that he acted as Member of the Supervisory Board since April 27, 2012 and Chairman of the Management Board and Chief Executive Officer of the Company since April 26, 2002. Mr. Wenning is Chairman of the Supervisory Board of Bayer Schering Pharma AG. He joined Company in 1966 as a commercial trainee. He held a number of positions with Bayer in Germany and abroad, serving as managing director of Bayer subsidiaries in Peru and Spain and later as Head of the Corporate Planning and Controlling Division. Mr. Wenning was appointed to the Board of Management as Chief Financial Officer in February 1997. Since September 2005 he has also been President of the German Chemical Industry Association. Mr. Wenning is also Vice President of the Federation of German Industries and a Member of the Supervisory Board of Henkel KGaA and Evonik Industries AG.
Marijn Dekkers	Dr. Marijn E. Dekkers has been Chairman of the Management Board and Chief Executive Officer of Bayer AG since October 1, 2010. He served as Member of the Management Board at the Company as of January 1, 2010. He began his career in the central research department of General Electric in Schenectady, New York. Two years later, Dr. Dekkers transferred to the GE Plastics research facility at Bergen op Zoom in the Netherlands. In 1988 he returned to the corporate research center to become Head of polymer materials research. After that, Dr. Dekkers held further management positions in various polymers units of GE. In 1995 he joined Allied Signal (subsequently Honeywell International Inc.) in Morristown, New Jersey. In the period through the end of 1999 he headed this company’s Specialty Films and Fluorine Chemicals business groups and then the Electronic Materials division in San Jose in California’s Silicon Valley. In 2000 Dr. Dekkers accepted an offer from Boston-based Thermo Electron Corporation. There he initially served as Chief Operating Officer. Two years later he was appointed the company’s President and Chief Executive Officer. Dr. Dekkers received a Bachelor degree in Chemistry from University of Nijmegen and a Master degree as well as a Doctorate in Chemistry from Technische Universiteit Eindhoven.
Hermann Strenger
Thomas de Win	Mr. Thomas de Win has been Vice Chairman of the Supervisory Board at Bayer AG since March 2, 2006. In addition, he acts as Member of the Company's Presidial Committee/Mediation Committee as well as Audit Committee. Mr. de Win joined Bayer AG in 1974. From 1975 to 1978 he trained as an office management assistant. On completion of his vocational training Mr. de Win worked in the administration of Bayer AG. Between 1976 and 1984 he held various positions in the Central Representative Body for Young Workers and Trainees. After completing his civilian service (1980 to 1981), Mr. de Win became a Member of the Bayer AG Works Council in 1984. Since 1989 he has been released for service as a Works Council Member. In 1998 Mr. de Win was elected Deputy Chairman of the Works Council. Since that time he has been a Member of both the Central and Group Works Councils. One year later he became Deputy Chairman of the Bayer Central Works Council. In 2001 he was elected to the National Board of the German Mine, Chemical and Power Workers' Union. Mr. de Win is Chairman of the Bayer Group Works Council as well as Bayer Central Works Council. He is also Member of the Supervisory Board of Bayer MaterialScience AG.
Werner Baumann	Mr. Werner Baumann has been Member of the Management Board responsible for Finance at Bayer AG since May 1, 2010. After studying Economics at RWTH Aachen University and the University of Cologne, he joined Bayer AG in 1988. His first duties were in the Corporate Finance Department in Leverkusen. In 1991 Mr. Baumann transferred to Bayer Hispania Comercial in Barcelona, Spain, to take up a position as Controller, becoming Assistant to the Managing Director in 1995. A year later, he moved to Bayer Corporation in Tarrytown, New York, latterly heading up the global Business Planning and Administration organization of the Diagnostics Business Group. In July 2002, Mr. Baumann returned to Germany to become Member of the Executive Committee and Head of Central Administration and Organization at Bayer HealthCare. In October 2003 he was appointed Member of the Board of Management of the newly formed subgroup Bayer HealthCare AG, also serving as the company’s Labor Director. As Member of the Board of Management and Labor Director of Bayer Schering Pharma, Berlin, Germany, from 2006 through September 2009, he actively participated in this company’s integration into the subgroup. Until December 31, 2009 Mr. Baumann also served on the Board of Bayer Business Services GmbH and until March 31, 2009 he was active on the Board of DIREVO Biotech AG. Since May 1, 2010 Mr. Baumann also has been active as Chairman of the Board at Bayer Business Services GmbH and Bayer CropScience AG.
Wolfgang Plischke	Dr. Wolfgang Plischke has been Member of the Management Board, responsible for Innovation, Technology and Environment at Bayer AG since March 1, 2006. He is Chairman of the Supervisory Board of Bayer MaterialScience AG and Bayer Technology Services GmbH. From July 1, 2002 until his appointment to the Bayer AG Board, he was a Member of the Bayer HealthCare Executive Committee and head of the Pharmaceuticals Division. In 1988, he was placed in charge of marketing in the Pharmaceuticals Business Group in Germany and in 1991 he was appointed head of International Strategic Marketing. In 1995, he became President of Bayer Yakuhin Ltd., Japan, with responsibility for Pharmaceuticals and Consumer Care. In 2000, Dr. Plischke took over as head of the Pharmaceuticals Business Group in North America. Dr. Plischke studied Biology at Universitaet Hohenheim before starting his career in 1980 with Bayer's subsidiary, Miles Diagnostics.
Michael Koenig	Mr. Michael Koenig has been Member of the Management Board responsible for Human Resources of Bayer AG since April 1, 2013. He is also responsible for the Latin America, Africa and Middle East regions and the subsidiary Currenta. After studying chemical process engineering at Technische Universitaet Dortmund and performing his compulsory military service, Mr. Koenig joined Bayer as a process engineer for chemicals projects in Europe. He assumed a variety of engineering-related positions of increasing responsibility in the areas of engineering, process development and maintenance management. He transferred to China in 2000 to become General Manager of Bayer Polymers Shanghai Co. Ltd. There he oversaw the construction of the new production site, the Bayer Integrated Site Shanghai, and was made site manager in 2002. Thereafter he served as Global Head of Production and Technology Isocyanates at Bayer Material Science. On April 1, 2007, Mr. Koenig became Senior Bayer Representative for the Greater China country group and Senior Country Representative for Bayer MaterialScience in China. He was Head of Bayer MaterialScience's Polycarbonate Business Unit from July 1, 2011, until his appointment to the Bayer Board of Management. He was also the member of the Bayer MaterialScience Executive Committee responsible for the Asia/Pacific region.
Paul Achleitner	Dr. Paul Achleitner has been Member of the Supervisory Board at Bayer AG since April 26, 2002. In addition, he acts as Member of the Company's Presidial Committee/Mediation Committee as well as the Nominations Committee. Until February 7, 2008 Dr. Achleitner was Chairman of the Supervisory Board of Allianz Elementar Lebensversicherungs-AG and Allianz Elementar Versicherungs-AG, and Vice Chairman of the Supervisory Board of Allianz Investment Bank. He was Member of the Supervisory Board of Allianz Lebensversicherungs-AG until May 7, 2008. Until the end of June 2010 he served on the Supervisory Board of Allianz Deutschland AG. In addition, Dr. Achleitner is Member of the Supervisory Board of Allianz Global Investors AG, RWE AG and as of April 2010 also of Daimler AG. Furthermore, he occupies the position of Chairman of the Board of Directors at Allianz Investment Management SE. He holds a degree from Harvard University and earned a Doctorate in Philosophy degree from Universitaet St. Gallen.
Clemens Boersig	Dr. Clemens A. H. Boersig has been Member of the Supervisory Board at Bayer AG since April 2007. Dr. Boersig served as Member of the Supervisory Board of Deutsche Lufthansa AG until April 29, 2008. He occupies the position of Chairman of the Supervisory Board at Deutsche Bank AG. Furthermore, he serves on the Supervisory Board of Daimler AG, Linde AG as well as Emerson Electric Co. In 1973 he obtained a degree in Mathematics as well as Business Administration from Universitaet Mannheim (University of Mannheim). He also earned a Doctorate degree in Economics from Universitaet Mannheim in 1975.
Thomas Ebeling	Mr. Thomas Ebeling has been appointed Member of the Supervisory Board of Bayer AG with effect from April 27, 2012. He is Chairman of the Supervisory Board at ProSiebenSat.1 Media AG.
Thomas Fischer	Dr. Thomas Fischer has been Member of the Supervisory Board at Bayer AG since October 1, 2005. Additionally, he acts as Member of the Audit Committee of the Company. Dr. Fischer is Member of the Supervisory Board of Bayer MaterialScience AG and Chairman of the Group Managerial Employees’ Committee of Bayer AG.
Peter Hausmann	Mr. Peter Hausmann has been Member of the Supervisory Board at Bayer AG since April 28, 2006. In addition, he acts as Member of the Audit Committee of the Company. Until November 6, 2009 he was North Rhine District Secretary of the German Mine, Chemical and Industrial Union until November 6, 2009. Furthermore, he was Member of the Supervisory Board of Evonik Services GmbH until December 2011. Since October 13, 2009 Mr. Hausmann has served as Member of the Executive Committee of the German Mining, Chemical and Energy Industrial Union.
Reiner Hoffmann	Mr. Reiner Hoffmann has been Member of the Supervisory Board at Bayer AG since October 11, 2006. He is North Rhine District Secretary of the German Mining, Chemical and Energy Industrial Union. Furthermore, Mr. Hoffmann also serves as Member of the Supervisory Board at SASOL Germany GmbH and as of September 2010 also at Evonik Services GmbH.
Yueksel Karaaslan	Mr. Yueksel Karaaslan has served as Member of the Supervisory Board of Bayer AG since April 27, 2012. He also acts as Chairman of the Works Council of the Berlin site of Bayer, Vice Chairman of the Bayer Central Works Council and Member of the Supervisory Board of Bayer Pharma AG.
Klaus Kleinfeld	Dr. Klaus Kleinfeld has been Member of the Supervisory Board at Bayer AG since April 29, 2005. Currently, Dr. Kleinfeld occupies the position of Chairman and Chief Executive Officer at ALCOA Inc. in New York, the United States. He received a Master degree in Economics and Business Administration from Georg-August-Universitaet Goettingen. He also holds a Doctorate in Philosophy degree in Strategic Management from Fachhochschule Wuerzburg-Schweinfurt.
Petra Kronen	Ms. Petra Kronen has been Member of the Supervisory Board at Bayer AG since July 2000. Additionally, she acts as Member of the Human Resources Committee of the Company. Ms. Kronen is active as Chairwoman of the Works Council of the Uerdingen site at Bayer AG. Moreover, she also serves as Vice Chairwoman of the Supervisory Board at Bayer MaterialScience AG as of December 7, 2009.
Helmut Panke	Dr. Helmut Gunter Wilhelm Panke has been Member of the Supervisory Board at Bayer AG since April 27, 2007. He is former Chairman of the Board of Management of BMW AG, Munich. Dr. Panke serves on the Supervisory Board of Microsoft Corporation, Singapore Airlines Limited and UBS AG. He holds a Doctorate in Physics from Ludwig-Maximilians-Universitaet Muenchen.
Sue Rataj	Ms. Sue H. Rataj has been appointed Member of the Supervisory Board at Bayer AG with effect from April 27, 2012. She is Member of the Board of Directors at Cabot Corporation.
Petra Reinbold-Knape	Ms. Petra Reinbold-Knape has served as Member of the Supervisory Board of Bayer AG since April 27, 2012. She also acts as Northeast District Secretary of the German Mining, Chemical and Energy Industrial Union, and Member of the Supervisory Board at envia Mitteldeutsche Energie AG, Vattenfall Europe Genera tion AG, Vattenfall Europe Business Services GmbH (until May 2012), among others.
Michael Schmidt-Kiessling	Mr. Michael Schmidt-Kiessling has served as Member of the Supervisory Board of Bayer AG since April 27, 2012. He also is Vice Chairman of the Works Council of the Elberfeld site of Bayer and Member of the Supervisory Board at Bayer Pharma AG.
Ekkehard Schulz	Dr. Ekkehard D. Schulz has been Member of the Supervisory Board at Bayer AG since April 29, 2005. He was Chairman of the Supervisory Board of ThyssenKrupp Services AG until September 30, 2009 and of ThyssenKrupp Technologies AG until October 11, 2009. Until January 2011, he served as Chairman of the Supervisory Board of ThyssenKrupp Elevator AG as well as ThyssenKrupp Steel Europe AG. He occupies the position of Chairman of the Executive Board at ThyssenKrupp AG. Dr. Schulz also serves as Member of the Supervisory Board at AXA Konzern AG and RWE AG. In addition, he acts as Vice Chairman of the Supervisory Board of MAN SE.
Klaus Sturany	Dr. Klaus Sturany has been Member of the Supervisory Board at Bayer AG since April 27, 2007. Additionally, Dr. Sturany acts as Chairman of the Company's Audit Committee. He was Member of the Executive Board of RWE AG until April 30, 2007. Dr. Sturany was Member of the Supervisory Board of Commerzbank AG until May 15, 2008. He serves as Vice Chairman of the Supervisory Board of Hannover Rueckversicherung AG and as Member of the Supervisory Board at Heidelberger Druckmaschinen AG, Oesterreichische Industrieholding AG and Sulzer AG. He holds a Doctorate degree in Mathematics from Universitaet Innsbruck, which he gained in 1970, and holds a degree in Economics from Johannes Keppler Universitaet Linz.
Andre van Broich	Mr. Andre van Broich has served as Member of the Supervisory Board of Bayer AG since April 27, 2012. He also acts as Chairman of the Works Council of the Dormagen site of Bayer and Member of the Supervisory Board at Bayer CropScience AG.
Ernst-Ludwig Winnacker	Prof. Dr. Ernst-Ludwig Winnacker has been Member of the Supervisory Board at Bayer AG since April 1997. He is former President of the German Research Foundation in Bonn. In addition, he is Secretary General of the Human Frontier Science Program as of July 1, 2009. Furthermore, Prof. Dr. Winnacker acts as Member on the Supervisory Board of Wacker Chemie AG and occupies the position of Chairman of the Supervisory Board at Medigene AG.
Oliver Zuehlke	Mr. Oliver Zuehlke has been Member of the Supervisory Board at Bayer AG since April 27, 2007. Until December 30, 2008 he was Member of the Supervisory Board of Bayer HealthCare AG. Mr. Zuehlke is Chairman of the Works Council of the Leverkusen site of Bayer AG and is Chairman of the Bayer European Forum.
Alexander Rosar

Basic Compensation

Name	Fiscal Year Total
Werner Wenning	92,000
Marijn Dekkers	5,062,000
Hermann Strenger	--
Thomas de Win	225,000
Werner Baumann	2,971,000
Wolfgang Plischke	2,495,000
Michael Koenig	--
Paul Achleitner	160,000
Clemens Boersig	113,000
Thomas Ebeling	83,000
Thomas Fischer	162,000
Peter Hausmann	141,000
Reiner Hoffmann	154,000
Yueksel Karaaslan	83,000
Klaus Kleinfeld	111,000
Petra Kronen	142,000
Helmut Panke	112,000
Sue Rataj	83,000
Petra Reinbold-Knape	84,000
Michael Schmidt-Kiessling	83,000
Ekkehard Schulz	155,000
Klaus Sturany	210,000
Andre van Broich	84,000
Ernst-Ludwig Winnacker	112,000
Oliver Zuehlke	134,000
Alexander Rosar	--

As Of 30 Dec 2012

Options Compensation

Name	Options	Value
Werner Wenning	0	0
Marijn Dekkers	0	0
Hermann Strenger	0	0
Thomas de Win	0	0
Werner Baumann	0	0
Wolfgang Plischke	0	0
Michael Koenig	0	0
Paul Achleitner	0	0
Clemens Boersig	0	0
Thomas Ebeling	0	0
Thomas Fischer	0	0
Peter Hausmann	0	0
Reiner Hoffmann	0	0
Yueksel Karaaslan	0	0
Klaus Kleinfeld	0	0
Petra Kronen	0	0
Helmut Panke	0	0
Sue Rataj	0	0
Petra Reinbold-Knape	0	0
Michael Schmidt-Kiessling	0	0
Ekkehard Schulz	0	0
Klaus Sturany	0	0
Andre van Broich	0	0
Ernst-Ludwig Winnacker	0	0
Oliver Zuehlke	0	0
Alexander Rosar	0	0

Insider Trading

» Full list on Insider Trading

People: Bayer AG (BAYZF.PK)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: